Search Results

The m7G Methyltransferase Mettl1 Drives Cardiac Hypertrophy by Regulating SRSF9‐Mediated Splicing of NFATc4.

• Authors : Yu, Shuting; Sun, ZhiYong; Ju, Tiantian

Subjects: CARDIAC hypertrophy; ALTERNATIVE RNA splicing; ANGIOTENSIN II

• Source: Advanced Science; 8/7/2024, Vol. 11 Issue 29, p1-18, 18p

Record details

LTBP2 Knockdown Ameliorates Cardiac Fibrosis and Apoptosis via Attenuating NF‐κB Signaling Pathway and Oxidative Stress in Mice with Cardiac Hypertrophy.

• Authors : Wang, Yifeng; Hua, Dongxu; Zhao, Kun

• Source: Advanced Therapeutics; Aug2024, Vol. 7 Issue 8, p1-12, 12p

Record details

Heparanase Stimulation of Physiologic Cardiac Hypertrophy Is Suppressed After Chronic Diabetes, Resulting in Cardiac Remodeling and Dysfunction.

• Authors : Lee, Chae Syng; Shang, Rui; Wang, Fulong

Subjects: CARDIAC hypertrophy; HEART cells; HEPARANASE

• Source: Diabetes; Aug2024, Vol. 73 Issue 8, p1300-1316, 17p

Record details

Inhibition of N-acetylglucosaminyltransferase V alleviates diabetic cardiomyopathy in mice by attenuating cardiac hypertrophy and fibrosis.

• Authors : Zhao, Ran; Hu, Jianqiang; Wen, He

Subjects: IN vitro studies; GLUCOSE; PROTEINS

• Source: Nutrition & Metabolism; 7/30/2024, Vol. 21 Issue 1, p1-16, 16p

Record details

Isoproterenol induced cardiac hypertrophy: A comparison of three doses and two delivery methods in C57BL/6J mice.

• Authors : Perez-Bonilla, Patricia; LaViolette, Brianna; Bhandary, Bidur

Subjects: CARDIAC hypertrophy; LABORATORY mice; ISOPROTERENOL

• Source: PLoS ONE; 7/22/2024, Vol. 19 Issue 7, p1-20, 20p

Record details

Therapeutic Inhibition of LincRNA-p21 Protects Against Cardiac Hypertrophy.

• Authors : Yi Wang; Mingming Zhang; Rong Wang

• Source: Circulation Research; 7/19/2024, Vol. 135 Issue 3, p434-449, 16p

Record details

The role of miR‐128 and MDFI in cardiac hypertrophy and heart failure: Mechanistic.

• Authors : Yanjun, Sun; Yunfen, Gu; Haoyi, Yao

Subjects: CARDIAC hypertrophy; GENE expression; WESTERN immunoblotting

• Source: Journal of Cellular & Molecular Medicine; Jul2024, Vol. 28 Issue 14, p1-10, 10p

Record details

Cardiomyocyte‐specific overexpression of FPN1 diminishes cardiac hypertrophy induced by chronic intermittent hypoxia.

• Authors : Song, Ji‐Xian; Xu, Shan; Chen, Qi

Subjects: CARDIAC hypertrophy; HEART diseases; HEPCIDIN

• Source: Journal of Cellular & Molecular Medicine; Jul2024, Vol. 28 Issue 14, p1-18, 18p

Record details

Mitochondria and NLRP3 inflammasome in cardiac hypertrophy.

• Authors : Yan, Ruyu; Sun, Yuxin; Yang, Yifan

• Source: Molecular & Cellular Biochemistry; Jul2024, Vol. 479 Issue 7, p1571-1582, 12p

Record details

Cardiac hypertrophy that affects hyperthyroidism occurs independently of the NLRP3 inflammasome.

• Authors : Parletta, Aline Cristina; Cerri, Gabriela Cavazza; Gasparini, Claudia Ribeiro Borba

Subjects: CARDIAC hypertrophy; NLRP3 protein; INFLAMMASOMES

• Source: Pflügers Archiv: European Journal of Physiology; Jul2024, Vol. 476 Issue 7, p1065-1075, 11p

Record details